Jason Rupp, former AdvaMed executive is named executive director for Southeastern Medical Device Association (SEMDA).
The Southeastern Medical Device Association (SEMDA) has named former AdvaMed executive Jason Rupp as its first full time executive director.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; GPOs: Premier buys the rest of direct sourcer S2S Global; CareFusion crushes it in final quarter; BD beats Q1 estimates, raises outlook, shares jump; Zimmer revises Biomet bid for EU regulators
Zimmer revises its $13 billion bid for crosstown rival Biomet in a further effort to mollify European anti-trust regulators, saying it thinks the deal is still on track to close during the 1st quarter.
Zimmer and Biomet are on track to close their $13 billion merger in the 1st quarter, Zimmer CEO David Dvorak said during a conference call discussing the orthopedic giant's 4th-quarter results.
Biomet reports surging profits during its fiscal 2nd quarter, citing a nearly $70 million decrease in legal costs compared with the same period last year.
Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy
, Becton Dickinson & Co.
, CareFusion Corp.
, Danaher Corp.
, Devicor Medical Products
, European Commission
, Leica Biosystems
, PneumRx Inc.
Zimmer proposes to mollify European anti-trust regulators on its pending, $13 billion acquisition of rival Biomet by selling off some of its knee and elbow assets in Europe.